Literature DB >> 28476918

Endothelial cAMP deactivates ischemia-reperfusion-induced microvascular hyperpermeability via Rap1-mediated mechanisms.

Adam H Korayem1,2, Patricio E Mujica2, Haruo Aramoto1, Ricardo G Durán1, Prerna R Nepali2, David D Kim1, Andrew L Harris1,2, Fabiola A Sánchez3, Walter N Durán4,2.   

Abstract

Approaches to reduce excessive edema due to the microvascular hyperpermeability that occurs during ischemia-reperfusion (I/R) are needed to prevent muscle compartment syndrome. We tested the hypothesis that cAMP-activated mechanisms actively restore barrier integrity in postischemic striated muscle. We found, using I/R in intact muscles and hypoxia-reoxygenation (H/R, an I/R mimic) in human microvascular endothelial cells (HMVECs), that hyperpermeability can be deactivated by increasing cAMP levels through application of forskolin. This effect was seen whether or not the hyperpermeability was accompanied by increased mRNA expression of VEGF, which occurred only after 4 h of ischemia. We found that cAMP increases in HMVECs after H/R, suggesting that cAMP-mediated restoration of barrier function is a physiological mechanism. We explored the mechanisms underlying this effect of cAMP. We found that exchange protein activated by cAMP 1 (Epac1), a downstream effector of cAMP that stimulates Rap1 to enhance cell adhesion, was activated only at or after reoxygenation. Thus, when Rap1 was depleted by small interfering RNA, H/R-induced hyperpermeability persisted even when forskolin was applied. We demonstrate that 1) VEGF mRNA expression is not involved in hyperpermeability after brief ischemia, 2) elevation of cAMP concentration at reperfusion deactivates hyperpermeability, and 3) cAMP activates the Epac1-Rap1 pathway to restore normal microvascular permeability. Our data support the novel concepts that 1) different hyperpermeability mechanisms operate after brief and prolonged ischemia and 2) cAMP concentration elevation during reperfusion contributes to deactivation of I/R-induced hyperpermeability through the Epac-Rap1 pathway. Endothelial cAMP management at reperfusion may be therapeutic in I/R injury.NEW & NOTEWORTHY Here, we demonstrate that 1) stimulation of cAMP production deactivates ischemia-reperfusion-induced hyperpermeability in muscle and endothelial cells; 2) VEGF mRNA expression is not enhanced by brief ischemia, suggesting that VEGF mechanisms do not activate immediate postischemic hyperpermeability; and 3) deactivation mechanisms operate via cAMP-exchange protein activated by cAMP 1-Rap1 to restore integrity of the endothelial barrier.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  Rap1; capillary permeability; endothelium, cAMP; exchange protein activated by cAMP; inflammation; ischemia-reperfusion

Mesh:

Substances:

Year:  2017        PMID: 28476918      PMCID: PMC5538859          DOI: 10.1152/ajpheart.00002.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  57 in total

1.  VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide.

Authors:  Jerome W Breslin; Peter J Pappas; Joaquim J Cerveira; Robert W Hobson; Walter N Durán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-12       Impact factor: 4.733

Review 2.  Linking Rap to cell adhesion.

Authors:  Johannes L Bos
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

3.  S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability.

Authors:  Anita Guequén; Rodrigo Carrasco; Patricia Zamorano; Lorena Rebolledo; Pia Burboa; José Sarmiento; Mauricio P Boric; Adam Korayem; Walter N Durán; Fabiola A Sánchez
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-26       Impact factor: 4.733

4.  Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.

Authors:  Patrice M Becker; Johannes Waltenberger; Robin Yachechko; Tamara Mirzapoiazova; James S K Sham; Chun Geun Lee; Jack A Elias; Alexander D Verin
Journal:  Circ Res       Date:  2005-05-26       Impact factor: 17.367

Review 5.  The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review.

Authors:  F William Blaisdell
Journal:  Cardiovasc Surg       Date:  2002-12

6.  Differential expression of VEGF isoforms in mouse during development and in the adult.

Authors:  Y S Ng; R Rohan; M E Sunday; D E Demello; P A D'Amore
Journal:  Dev Dyn       Date:  2001-02       Impact factor: 3.780

7.  Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery.

Authors:  R H Adamson; J C Ly; R K Sarai; J F Lenz; A Altangerel; D Drenckhahn; F E Curry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-04       Impact factor: 4.733

8.  Rap1 mediates protective effects of iloprost against ventilator-induced lung injury.

Authors:  Anna A Birukova; Panfeng Fu; Junjie Xing; Konstantin G Birukov
Journal:  J Appl Physiol (1985)       Date:  2009-10-22

9.  VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.

Authors:  Tomohiko Usui; Susumu Ishida; Kenji Yamashiro; Yuichi Kaji; Vasiliki Poulaki; Johnny Moore; Tara Moore; Shiro Amano; Yoshitaka Horikawa; Darlene Dartt; Matthew Golding; David T Shima; Anthony P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

10.  Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.

Authors:  P K Dillon; W N Durán
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

View more
  6 in total

1.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

Review 2.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

3.  IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury.

Authors:  Shiqin Xiong; Zhigang Hong; Long Shuang Huang; Yoshikazu Tsukasaki; Saroj Nepal; Anke Di; Ming Zhong; Wei Wu; Zhiming Ye; Xiaopei Gao; Gadiparthi N Rao; Dolly Mehta; Jalees Rehman; Asrar B Malik
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

4.  Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovir.

Authors:  Dante A Suffredini; Yan Li; Wanying Xu; Mahtab Moayeri; Stephen Leppla; Yvonne Fitz; Xizhong Cui; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-09-08       Impact factor: 4.733

5.  Epac1 protects the retina against ischemia/reperfusion-induced neuronal and vascular damage.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

6.  QiShenYiQi Pills Attenuates Ischemia/Reperfusion-Induced Cardiac Microvascular Hyperpermeability Implicating Src/Caveolin-1 and RhoA/ROCK/MLC Signaling.

Authors:  Chun-Shui Pan; Li Yan; Se-Qi Lin; Ke He; Yuan-Chen Cui; Yu-Ying Liu; Bai-He Hu; Xin Chang; Xin-Rong Zhao; Jing-Yu Fan; Jing-Yan Han
Journal:  Front Physiol       Date:  2021-12-17       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.